| ||
Teva Pharmaceutical to present GALA study results of GA to treat relapsing ... pharmabiz.com Teva Pharmaceutical Industries Ltd, a leading global pharmaceutical company, has announced data from the phase III Glatiramer Acetate Low-Frequency Administration (GALA) study. The GALA study was designed to evaluate the efficacy, safety and ... See all stories on this topic » | ||
Impax Pharmaceuticals Announces Extension of RytaryTM FDA Review Date to ... DailyFinance Impax Pharmaceuticals and GSK announced an agreement for the development and commercialization of IPX066 in December 2010. Under the terms of the agreement, GSK received an exclusive license to register and commercialize IPX066 throughout the ... See all stories on this topic » | ||
Mistakes, and meningitis Los Angeles Times The 14 people who died of fungal meningitis after they were injected with an apparently tainted steroid surely had no idea that their medication hadn't come from a regular pharmaceutical company that meets federal standards for safety and efficacy ... See all stories on this topic » | ||
J&J 3Q report to focus on pharmaceutical business Businessweek WHAT TO WATCH FOR: J&J, based in New Brunswick, N.J., will focus on its pharmaceutical business, including sales trends for hepatitis C treatment Incivo and other new medicines, as well as progress on drugs in development. Analysts will be listening ... See all stories on this topic » | ||
6 Pharmaceutical Stocks to Buy Now Investorplace.com This week, Acura Pharmaceuticals (NASDAQ:ACUR) is showing significant improvement as the company's rating hops from a C ("hold") to a B ("buy"). Acura Pharmaceuticals engages in the research, development, and manufacture of pharmaceutical product ... See all stories on this topic » | ||
| ||
| ||
Pharmaceutical firms targeted in meningitis case hire defense lawyer Yahoo! News (blog) BOSTON (Reuters) - The pharmaceutical companies at the center of the deadly meningitis outbreak have disclosed they hired a lawyer from a top white-collar criminal-defense firm in Boston. New England Compounding Center, Ameridose LLC and Alaunus ... See all stories on this topic » | ||
GW Pharmaceuticals gets more clinical backing ShareCast GW Pharmaceuticals gets more clinical backing LONDON (SHARECAST) - GW Pharmaceuticals, the British biotech firm, has seen clinical data released by partner Almirall that gives further backing for the efficacy of GW's cannabis-based drug, Sativex. See all stories on this topic » | ||
Strong performance in US to boost Indian pharmaceutical companies Economic Times 12 Oct, 2012, 11.10AM IST, The writer has posted comments on this article Kiran Kabtta SomvanshiKiran Kabtta Somvanshi,ET Bureau. Strong performance in US to boost Indian pharmaceutical companies. Story; Comments. Post a comment. Email this article ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment